VOLULYTE 6% infusion solution medication leaflet

B05AA07 hydroxyethyl starch • Blood and blood forming organs | Blood and related products | Blood substitutes and plasma protein fractions

Hydroxyethyl starch is a solution used as a plasma volume substitute in the treatment of hypovolemia caused by acute blood loss. It works by increasing intravascular volume, helping to maintain blood pressure and tissue perfusion.

The medication is administered via intravenous infusion under the supervision of a specialist.

Side effects may include allergic reactions, pruritus, coagulation disorders, or kidney dysfunction. In rare cases, anaphylactic reactions may occur.

Patients should be closely monitored during administration and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.

General data about VOLULYTE 6%

Substance: hydroxyethyl starch

Date of last drug list: 01-06-2025

Commercial code: W54129012

Concentration: 6%

Pharmaceutical form: infusion solution

Quantity: 20

Product type: original

Price: 654.57 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: FRESENIUS KABI DEUTSCHLAND GMBH - GERMANIA

Holder: FRESENIUS KABI ROMANIA S.R.L. - ROMANIA

Number: 10443/2017/12

Shelf life: 3 years

Concentrations available for hydroxyethyl starch

10%, 100g/L, 100mg/ml, 6%, 60g/1000ml, 60g/L, 60mg/ml, 6g/100ml